By Mark Terry, BioSpace.com Breaking News Staff
BioSpace (DHX) is pleased to present its NextGen Bio “Class of 2016.” This list contains 20 life science companies that launched no earlier than 2013 and are headquartered in the United States. Once BioSpace sorted the companies into that group, they were then weighted by a number of different categories and ranked in a cumulative fashion based on the points awarded for each category. These categories are: Finance, Collaborations, Pipeline, Sales and Editorial (view methodology).
The NextGen Bio Class of 2016 is a stellar group of companies that are already making an enormous impact on the industry now and in the future. Congratulations!
California led the way in the NextGen Bio “Class of 2016” with half of the companies in the Top 20, followed by Massachusetts with five, and one company each in New Jersey, Texas, New York, Washington and North Carolina.
Nice to have one of the top 20 right here in Texas.
8. Aeglea BioTherapeutics
Points: 9
Founded: 2013
Location: Austin, Tex.
Notable:
- Aeglea was founded in December 2013 to develop engineered human enzymes invented in the laboratory of George Georgiou of The University of Texas at Austin.
- Four drug candidates that degrade specific amino acids in the circulation are in development for the treatment of cancer and inborn errors of metabolism.
- In January 2014, the company closed on a $12 million Series A round.
- In March 2015, it closed on a $44 million Series B round.
- The company has filed an investigational new drug (IND) application with the U.S. Food and Drug Administration (FDA) for AEB1102 for the treatment of solid tumors. It initiated a Phase I dose escalation study.
